SeQuent Scientific Ltd
SEQUENTSeQuent Scientific Ltd
SEQUENT
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -15.63 | 2.94 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 40.05 | 4.70 | 0.78% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
SeQuent Scientific Limited is a holding company that operates in pharmaceutical sector.
Investor Presentation
View olderPeers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 508.13 | 621.08 | 694.65 | 1,292.62 | 1,047.98 | 1,189.33 | 1,369.98 | 1,423.67 | 1,427.30 | 1,419.11 | ||||||||||
Raw Materials | 223.01 | 293.07 | 366.89 | 486.44 | 570.52 | 600.59 | 733.68 | 842.41 | 814.87 | 1,496.31 | ||||||||||
| Power & Fuel Cost | 23.32 | 26.51 | 12.77 | 14.66 | 23.06 | 24.73 | 28.75 | 33.86 | 42.45 | |||||||||||
| Employee Cost | 61.11 | 86.67 | 106.22 | 113.83 | 145.95 | 165.06 | 187.22 | 231.37 | 258.39 | |||||||||||
| Selling & Administrative Expenses | 42.45 | 55.11 | 74.68 | 94.72 | 90.93 | 108.27 | 115.85 | 132.65 | 139.02 | |||||||||||
| Operating & Other expenses | 91.88 | 89.67 | 82.59 | 64.28 | 83.92 | 110.27 | 92.86 | 63.12 | 219.02 | |||||||||||
EBITDA | 66.36 | 70.05 | 51.50 | 518.69 | 133.60 | 180.41 | 211.62 | 120.26 | -46.45 | -77.20 | ||||||||||
| Depreciation/Amortization | 31.75 | 45.72 | 40.07 | 41.34 | 41.92 | 50.62 | 50.60 | 51.54 | 55.69 | 56.00 | ||||||||||
| PBIT | 34.61 | 24.33 | 11.43 | 477.35 | 91.68 | 129.79 | 161.02 | 68.72 | -102.14 | -133.20 | ||||||||||
| Interest & Other Items | 42.98 | 38.15 | 28.34 | 33.07 | 32.80 | 35.71 | 24.38 | 15.77 | 35.52 | 39.20 | ||||||||||
| PBT | -8.37 | -13.82 | -16.91 | 444.28 | 58.88 | 94.08 | 136.64 | 52.95 | -137.66 | -172.40 | ||||||||||
| Taxes & Other Items | 2.37 | 4.65 | -3.08 | 22.72 | 10.22 | 24.17 | 41.19 | 11.98 | -16.50 | -31.35 | ||||||||||
| Net Income | -10.74 | -18.47 | -13.83 | 421.56 | 48.66 | 69.91 | 95.45 | 40.97 | -121.16 | -141.05 | ||||||||||
| EPS | -0.14 | -0.34 | -0.53 | 15.98 | 1.91 | 2.82 | 3.84 | 1.65 | -4.87 | -5.65 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.18 | 0.20 | 0.00 | 0.50 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.10 | 0.00 | 0.13 | 0.00 | 0.00 | 0.00 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| SeQuent Scientific Ltd | -18.20 | 2.94 | — |
| Sun Pharmaceutical Industries Ltd | 32.45 | 4.64 | 1.00% |
| Cipla Ltd | 34.76 | 4.11 | 0.70% |
| Dr Reddy's Laboratories Ltd | 20.93 | 4.05 | 0.71% |
Price Comparison
Compare SEQUENT with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 3 Mutual Funds holding SeQuent Scientific Ltd
| Funds (Top 3) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
UTI Healthcare Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.2616% | Percentage of the fund’s portfolio invested in the stock 0.74% | Change in the portfolio weight of the stock over the last 3 months -0.06% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 32/36 (-1) |
ITI PHARMA AND HEALTHCARE FUND - DIRECT PLAN - GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0497% | Percentage of the fund’s portfolio invested in the stock 0.78% | Change in the portfolio weight of the stock over the last 3 months 0.78% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 38/40 (-1) |
Motilal Oswal Nifty Microcap 250 Index Fund- Direct- Growth Option Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0367% | Percentage of the fund’s portfolio invested in the stock 0.25% | Change in the portfolio weight of the stock over the last 3 months 0.25% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 166/252 (-10) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 8, 2021
Dividend/Share
₹0.50
Ex DateEx Date
Sep 8, 2021
Cash Dividend
Ex DateEx DateAug 21, 2019
Dividend/Share
₹0.20
Ex DateEx Date
Aug 21, 2019
Cash Dividend
Ex DateEx DateNov 20, 2017
Dividend/Share
₹0.20
Ex DateEx Date
Nov 20, 2017
Cash Dividend
Ex DateEx DateSep 16, 2011
Dividend/Share
₹1.50
Ex DateEx Date
Sep 16, 2011
Cash Dividend
Ex DateEx DateSep 23, 2010
Dividend/Share
₹2.00
Ex DateEx Date
Sep 23, 2010
News & Opinions
Sensex tanks 366 points, Nifty settles below 19,450; Hindware Home, Sequent Scientific, Apollo Tyres down up to 13%
1 month ago•Business Today
Sequent Scienti Consolidated June 2023 Net Sales at Rs 333.21 crore, down 2.38% Y-o-Y
1 month ago•Moneycontrol
Sequent Scientific slumps 6% after Q1 loss widens to Rs 34.7 cr
1 month ago•Moneycontrol
Sequent Scientific shuts operation at Palghar plant; stock rises
2 months ago•Moneycontrol
SeQuent Scientific dips 2% after Q4 loss
4 months ago•Moneycontrol
Know your stock | Is there a glimmer of hope for SeQuent Scientific?
6 months ago•Moneycontrol
GRM Overseas Ltd leads losers in ‘A’ group
6 months ago•Business Standard
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 2%, vs industry avg of 8.45%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.64% to 0.45%